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Abstract
The sequencing of the human genome has provided tools
to gain a better understanding of the role of genes and
their interaction with environmental factors in the 
development of disease. However, much work remains in
translating discoveries into new opportunities for disease
prevention and health promotion. Both public health aca-
demia and practice have important roles to play in bridg-
ing the gap between the growth in knowledge stemming
from the Human Genome Project and its application in
public health. Recognizing this, the Centers for Disease
Control and Prevention, through the Association of
Schools of Public Health, established Centers for
Genomics and Public Health at three schools of public
health in 2001: the University of Michigan, the University
of North Carolina, and the University of Washington. This
paper describes the experience of the University of
Washington Center for Genomics and Public Health in
forging partnerships with public health practitioners to
translate genomic advances into public health practice.
Introduction
The sequencing of the human genome has provided tools
to gain a better understanding of the role of genes and
their interaction with environmental factors in disease
development (1). This understanding is predicted to
improve methods for targeting interventions aimed at pre-
venting disease and improving health. In the future, for
instance, some believe that individuals will be screened for
genetic susceptibility to common disorders such as cancer,
heart disease, and diabetes, thus yielding recommenda-
tions for personalized prevention strategies. Primary pre-
vention strategies (such as dietary changes) and secondary
prevention strategies (such as more frequent or earlier ini-
tiation of medical screening) might be used to minimize
disease risk (2). Disease management is expected to
improve through pharmacogenomics, which promises
safer and more efficacious drugs through the customiza-
tion of drug therapies based upon an individual’s genetic
makeup (3).
Much work remains, however, in translating discoveries
into new opportunities for disease prevention and health
promotion. While new reports of gene–disease associations
are published almost daily, most are not replicable (4).
Most chronic diseases are caused not by a single gene but
by the complex interplay among several genes and numer-
ous environmental factors. Therefore, population-based
studies that assess the prevalence of genotypes, the dis-
ease risk associated with gene variants, and gene–gene
and gene–environment interactions are needed (5).
Furthermore, as new genetic tests are developed, informa-
tion on their analytical validity (accuracy with which a
genetic characteristic can be detected in a given laborato-
ry test), clinical validity (accuracy with which a test pre-
dicts a clinical outcome), clinical utility (likelihood that the
test will lead to an improved health outcome), and ethical,
legal, and social consequences will be needed to make deci-
sions about their use in clinical and public health practice
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(6). The impact of genomic information on risk perception
and health behavior change needs to be better studied, and
the added value of targeted interventions based upon
genetic susceptibility compared with population-based pre-
vention recommendations needs to be determined (7).
Health care providers and public health professionals will
need to be educated about genomics (7) and the public will
need to be “genetically literate” if genomics is to be used as
a tool for disease prevention (8). Concerns about the use of
genomic information (e.g., fear of employment or insurance
discrimination) will need to be well understood through
community input and adequately addressed as programs or
policies incorporating genomics are developed (9).
The Centers for Genomics and Public
Health: Linking Academia and Practice
Both public health academia and practice have impor-
tant roles to play in bridging the gap between the growth
in knowledge stemming from the Human Genome Project
and its application in improving health and preventing
disease. Recognizing this, the Centers for Disease Control
and Prevention’s Office of Genomics and Disease
Prevention (CDC OGDP), through the Association of
Schools of Public Health, established Centers for
Genomics and Public Health at three schools of public
health in 2001: the University of Michigan, the University
of North Carolina, and the University of Washington. CDC
OGDP, which since 1997 has taken the lead in promoting
the use of genomics to improve health and prevent disease
across the lifespan by integrating genomics into public
health research, policy, and programs (10), established the
centers with the mission of further integrating genomics
into public health practice by increasing the genomics and
public health knowledge base; providing technical assis-
tance to local, state, and regional public health systems;
and training the public health workforce (11). In 2002, the
Institute of Medicine released the report Who Will Keep
the Public Healthy? Educating Public Health Professionals
for the 21st Century. The report acknowledged genomics as
an important component of public health and called upon
schools of public health to provide students and practicing
public health professionals with a framework for under-
standing the importance of genomics to public health (12).
Although the centers were established prior to develop-
ment of this report, they are clearly playing a role in
answering this call.
To accomplish their mission of further integrating
genomics into public health practice, particularly in the
area of chronic disease prevention, the centers have devel-
oped strong ties with public health practitioners within
state public health agencies and to a lesser extent with
practitioners at the local level. Both academics and practi-
tioners have benefited from partnerships through new
concepts and applications. For instance, though some
researchers within schools of public health have long been
engaged in a variety of research activities related to
genomics in the areas of biostatistics, epidemiology, envi-
ronmental and occupational health, health policy, health
services, and the behavioral sciences, these researchers
rarely engage in public health activities at the state or
local level, and many do not have a solid understanding of
public health in the real world. State health departments
have also been engaged in genomics activities for a num-
ber of years, ranging from newborn screening programs to
the provision of genetic services. However, a 2000 survey
of state health departments conducted by the Council of
State and Territorial Epidemiologists indicated that few
state health departments had begun to consider opportu-
nities for using genomics outside of the context of mater-
nal and child health, despite an increasing awareness of
the potential application of genomics in broader public
health efforts. Survey respondents identified lack of
resources, proven disease prevention measures, and out-
comes data as potential barriers (13). Through the centers,
academic researchers and public health practitioners have
begun to collaborate more closely, and opportunities for
using genomics to improve public health, particularly in
the area of chronic disease prevention, have been identi-
fied as a result. This paper describes the experience of the
University of Washington Center for Genomics and Public
Health (UWCGPH) in forging partnerships with public
health practitioners to translate genomic advances into
public health practice.
The University of Washington Center for
Genomics and Public Health
At UWCGPH, we have learned a tremendous amount
about how to develop genomics-centered collaborations
with state public health agencies, and these collaborations
enhance the work of both researchers and practitioners.
Relationship building is a first step toward identifying
opportunities for collaboration. Despite the distance that
may lie between universities and state health agencies,
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tant to developing relationships. We traveled from Seattle
to the Washington State Health Department (WA DOH) in
Olympia, Wash, numerous times to meet with chronic dis-
ease program staff. We also traveled to the Oregon Health
Division (OHD) in Portland to meet with genetics program
staff; Oregon is one of four states currently leading efforts
to integrate genomics into chronic disease with recent
funding from the CDC’s National Center for Chronic
Disease Prevention and Health Promotion (14). We
attended several public health conferences and participat-
ed in evaluating state public health programs to learn
more about public health activities in Washington. All
these efforts provided us with the opportunity to better
understand the role of state public health programs and
the knowledge and skills held by public health practition-
ers, as well as to share information about our expertise
and to work together to identify ways in which genomics
might be integrated into state public health efforts.
We have found that both formal and informal educa-
tional efforts are effective for stimulating interest in
genomics and encouraging ongoing learning about
genomics terms and concepts. For example, we collaborat-
ed with the CDC and other centers to develop an animat-
ed Web-based module, Genomics for Public Health
Practitioners: The Practical Application of Genomics in
Public Health Practice. Pilot testing of this module indi-
cates that it addresses many questions raised by public
health practitioners about the use of genomics in public
health. We also identified genomics training courses with-
in the Pacific Northwest for interested public health prac-
titioners to attend. While such formal educational efforts
are effective in some instances, we also believe that adding
genomics terms and concepts to the public health lexicon
can be accomplished through ongoing joint efforts between
the centers and state health departments. Over time, a
common understanding of terms and concepts begin to
emerge as academics and practitioners work together to
tackle issues.
To address the common notion that genomics is a sepa-
rate field, rather than an area that is becoming increas-
ingly relevant to almost every disease and public health
program area, we have learned the value of framing
genomics as an additional tool for informing and address-
ing public health issues. For example, we conducted a proj-
ect to examine the impact of genomics on public health
efforts to reduce asthma morbidity and mortality by using
a consultative process that engaged public health profes-
sionals, researchers, health care providers, and communi-
ty representatives in dialogue about this issue. The final
conclusions and recommendations drawn from this
process are summarized in a final report, Asthma
Genomics: Implications for Public Health (15). We hope
that by engaging a variety of experts in the examination
and dialogue process and by broadly disseminating the
final report, those involved in asthma public health efforts
at the local, state, and national levels will be more pre-
pared to manage issues that may arise with the use of
genomics to prevent, diagnose, and treat asthma and will
think more about how genomics might play a role in reduc-
ing the effects of this common disease.
Family history, which reflects the consequences of genet-
ic susceptibilities, shared environment, and common
behaviors, is a risk factor for almost all chronic diseases (7)
and can be incorporated into efforts to address many dis-
eases of public health importance. Although family history
has been long collected within the medical setting, there
have been few public health efforts promoting the use of
family history as a tool for disease prevention (16). In
2003, the CDC funded three sites to answer many impor-
tant questions regarding the use of family history in pub-
lic heath and preventive medicine (17). In the meantime,
however, state health agencies appear interested in play-
ing a role in answering important questions, including the
following: Can a simple family history tool accurately and
reliably collect information from family members? Can dis-
ease information about an individual’s relatives be used to
inform their risk for disease? If so, would individuals found
to be at increased risk be more likely to adopt lifestyle
changes and participate in early detection and prevention
strategies (16)?
Family history was a topic for which we identified oppor-
tunities for collaboration with the Washington State
Diabetes Prevention and Control Program (DPCP). For
example, we took part in an assessment of the Washington
State Diabetes Public Health System Performance, which
was aimed at identifying the strengths and weaknesses of
the statewide diabetes public health program.
Opportunities for improvement resulting from the assess-
ment included capturing the nonidentified diabetics in the
state, developing a robust research agenda relevant to dia-
betes public health practice, and developing strategies to
work more closely with academic partners. To help the WA
DOH address these identified gaps, we proposed to 
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develop a research project involving the use of family his-
tory as a public health tool. The Washington State
Collaborative (WSC) Adult Preventive Services, a system-
atic approach to health care quality improvement in which
organizations and providers test procedural innovations
and then share their experiences to accelerate learning
and promote widespread implementation of best practices,
was an ideal setting in which to perform this project. We
plan to collaborate with DPCP to collect more structured
family histories as part of the WSC’s quality improvement
efforts, as well as to provide training to physicians regard-
ing the utility of family history information.
After solid relationships with public health practitioners
have been developed, in which practitioners begin to
understand how genomics can be used as a tool for
addressing issues of public health importance and aca-
demics begin to understand how genomics fits within the
context of current public health programs and priorities,
collaborative projects aimed at integrating genomics into
public health are more easily identified. Funding for col-
laborative projects is an important issue, as state health
departments often do not have the resources to carry out
special projects.
In some instances, genomics-related projects can be pro-
posed within the context of larger public health program
proposals. For example, as a result of our efforts to demon-
strate the relevance of family history to diabetes public
health efforts, we were invited by the WA DOH to present
information on the use of family history as a potential pub-
lic health tool to those communities submitting proposals
to the U.S. Department of Health and Human Services ini-
tiative,  Steps to a HealthierUS. We suggested several
potential community projects, including a community
campaign to increase knowledge of family history. By
incorporating family history into a comprehensive disease
prevention and health promotion strategy, the communi-
ties would address many objectives of Steps to a
HealthierUS. The Washington communities received fund-
ing, and we plan to assist them in identifying ways in
which family history can be used to meet their goals.
Proposals also can be developed around other projects.
For example, to evaluate the potential use of family histo-
ry information, we are in the process of identifying funding
to pilot a family history tool in a sample of clinics partici-
pating in the WSC. In addition, some projects can be best
implemented in conjunction with the four states that have
obtained funding to address genomics and chronic disease
(14). For example, we are working with the health 
departments of the four states in reviewing existing fami-
ly history questions included on various state surveys (e.g.,
Behavioral Risk Factor Surveillance System) and in devel-
oping new questions about family history for such surveys.
Lastly, we have had discussions with OHD about 
collaborating on the development of a genomics awareness
campaign for the health agency.
Benefits of Using Academic–Practice
Collaborations
Because they have only been in existence for two and a
half years, it is difficult to fully assess the benefits of the
collaborations the centers have developed with their state
public health agency partners. Several benefits of these
academic–practice partnerships, however, have been casu-
ally observed. Academics have gained an awareness of
what public health practice means, including an apprecia-
tion for the valuable expertise held by program staff and
the day-to-day work they carry out. As a result, many have
become involved in practice-based research, teaching, and
service activities that they would have been less likely to
consider prior to the exposure to public health practice
afforded to them through these centers.
State public health departments are also taking better
advantage of the expertise held by public health genomics
researchers. For example, requests to the centers for guest
speakers at conferences and representatives for statewide
committees and taskforces have increased. Both academ-
ics and practitioners have come together to identify collab-
orative projects and opportunities to participate in
research aimed at questions of public health importance.
Lastly, public health students have gained invaluable
experience with real-world public health genomics issues
through their involvement in projects carried out through
the centers, creating a new generation of public health pro-
fessionals with exposure to genomics in practice. In some
cases, public health departments have benefited because
these students have tackled valuable projects that they
otherwise would not have had resources to address.
The academic–practice partnerships created through
the centers for Genomics and Public Health are slowly
transforming the landscape of public health genomics
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the centers and state health departments has created
partnerships in which both sides benefit and flourish.
The work of academics is informed and enriched by real-
world issues that affect real populations while the work
of public health practitioners is sharpened with the
developing knowledge and new approaches the academy
has to offer. This burgeoning synergy, strengthened by
time, shared experiences, and successes, is ultimately
greater than the sum of its parts and will be an impor-
tant element for the genomics revolution to maximally
benefit public health.
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